Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thimerosal provision has short shelf-life

Executive Summary

Omnibus appropriations bill expected to repeal provision in homeland security bill which required that claims related to vaccine components, including the preservative thimerosal, go through the Vaccine Injury Compensation Fund (1"The Pink Sheet" Nov. 18, 2002, p. 27). Sens. Lincoln Chafee (R-R.I.), Susan Collins (R-Maine), and Olympia Snowe (R-Maine) announce they have secured an agreement for the Senate to consider comprehensive legislation on overhauling the injury compensation system and encouraging vaccine development. The thimerosal provision was part of a broader bill sponsored by Senate Majority Leader Bill Frist (Tenn.)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS041109

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel